Effect aromatherapy on fatigue and quality of Sleep in hemodialysis patients
Not Applicable
- Conditions
- End Stage Renal Disease.Chronic uraemia End stage kidney diseaseN18.5 Chro
- Registration Number
- IRCT2016060222772N1
- Lead Sponsor
- Zabol University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Hemodialysis three times a week; having a history of Hemodialysis treatments more than six months; informed consent for the study; lack of acute stressful event in the past 6 months (Death of loved ones); lack of history of allergy to aromas; lack of proven problem in sense of smell (healthy olfactory sense that was evaluated by a physician).
Exclusion criteria: unwillingness to participate in the trial; kidney transplantation; hospitalization in another ward except Hemodialysis ward for other reason (MI, CVC and dyspnea).
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue. Timepoint: Before and end of first and second weeks in first stage of intervention stage and end of third and fourth Weeks in two stage of intervention. Method of measurement: multidimensional fatigue inventory (MFI-20).
- Secondary Outcome Measures
Name Time Method Quality of Sleep. Timepoint: Before and end of first and second weeks in first stage of intervention stage and end of third and fourth Weeks in two stage of intervention. Method of measurement: Pittsburgh Sleep Quality Index (PSQI).